Education
About Us
Working with TipRanks
Follow Us
Amedisys Inc (AMED)
NASDAQ:AMED
Total Valuation
Amedisys has a market cap or net worth of $3.00B. The enterprise value is $3.17B.
Market Cap$3.00B
Enterprise Value$3.17B
Share Statistics
Amedisys has 32.81M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32.81M
Owned by Insiders2.34%
Owned by Instutions38.96%
Financial Efficiency
Amedisys’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 2.48%.
Return on Equity (ROE)3.81%
Return on Assets (ROA)2.02%
Return on Invested Capital (ROIC)2.48%
Return on Capital Employed (ROCE)5.82%
Revenue Per Employee$123,596
Profits Per Employee$3,567.368
Employee Count19,000
Asset Turnover1.10
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Amedisys is 68.71. Amedisys’s PEG ratio is -0.13.
PE Ratio68.71
PS Ratio1.26
PB Ratio2.62
Price to Fair Value2.62
Price to FCF13.81
Price to Operating Cash Flow13.40
PEG Ratio-0.13
Income Statement
In the last 12 months, Amedisys had revenue of $2.35B and earned $67.78M in profits. Earnings per share was $2.08.
Revenue$2.35B
Gross Profit$751.75M
Operating Income$127.11M
Pretax Income$86.22M
Net Income$67.78M
EBITDA158.05M
Earnings Per Share (EPS)2.08
Cash Flow
In the last 12 months, operating cash flow was $221.66M and capital expenditures -$6.96M, giving a free cash flow of $214.71M billion.
Operating Cash Flow$221.66M
Free Cash Flow$214.71M
Free Cash Flow per Share$6.54
Dividends & Yields
Amedisys pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield7.24%
Earnings Yield1.46%
Stock Price Statistics
Beta0.23
52-Week Price Change0.10%
50-Day Moving Average92.20
200-Day Moving Average93.79
Relative Strength Index (RSI)40.87
Average Volume (3m)321.10K
Important Dates
Amedisys upcoming earnings date is Apr 23, 2025, After Close.
Last Earnings DateFeb 26, 2025
Next Earnings DateApr 23, 2025
Ex-Dividend Date―
Financial Position
Amedisys as a current ratio of 1.23, with Debt / Equity ratio of 0.41
Current Ratio1.23
Quick Ratio1.23
Debt to Market Cap0.15
Net Debt to EBITDA2.14
Interest Coverage Ratio3.07
Taxes
In the past 12 months, Amedisys has paid $23.11M in taxes.
Income Tax$23.11M
Effective Tax Rate55.74%
Enterprise Valuation
Amedisys EV to EBITDA ratio is 42.58, with an EV/FCF ratio of 14.54.
EV to Sales1.33
EV to EBITDA42.58
EV to Free Cash Flow14.54
EV to Operating Cash Flow14.11
Balance Sheet
Amedisys has $303.24M in cash and marketable securities with $460.18M in debt, giving a net cash position of $156.94M billion.
Cash & Marketable Securities$303.24M
Total Debt$460.18M
Net Cash$156.94M
Net Cash Per Share$4.78
Tangible Book Value Per Share-$3.52
Margins
Gross margin is 43.34%, with operating margin of 4.03%, and net profit margin of 1.84%.
Gross Margin43.34%
Operating Margin4.03%
Pretax Margin3.67%
Net Profit Margin1.84%
EBITDA Margin3.13%
EBIT Margin2.36%
Analyst Forecast
The average price target for Amedisys is $101.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$101.00
Price Target Upside10.45%
Analyst ConsensusHold
Analyst Count6
Revenue Growth Forecast5.01%
EPS Growth Forecast